Works matching IS 14655411 AND DT 2014 AND VI 16 AND IP 3


Results: 48
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.

    Published in:
    2014
    By:
    • O'Leary, Patrick C;
    • Terrile, Marta;
    • Bajor, Malgorzata;
    • Gaj, Pawel;
    • Hennessy, Bryan T;
    • Mills, Gordon B;
    • Zagozdzon, Agnieszka;
    • O'Connor, Darran P;
    • Brennan, Donal J;
    • Connor, Kate;
    • Li, Jane;
    • Gonzalez-Angulo, Ana Maria;
    • Sun, Han-Dong;
    • Pu, Jian-Xin;
    • Pontén, Fredrik;
    • Uhlén, Mathias;
    • Jirström, Karin;
    • Nowis, Dominika A;
    • Crown, John P;
    • Zagozdzon, Radoslaw
    Publication type:
    journal article
    20
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.

    Published in:
    Breast Cancer Research, 2014, v. 16, n. 3, p. 1, doi. 10.1186/bcr3669
    By:
    • Damiola, Francesca;
    • Pertesi, Maroulio;
    • Oliver, Javier;
    • Calvez-Kelm, Florence Le;
    • Voegele, Catherine;
    • Young, Erin L.;
    • Robinot, Nivonirina;
    • Forey, Nathalie;
    • Durand, Geoffroy;
    • Vallée, Maxime P.;
    • Tao, Kayoko;
    • Roane, Terrell C.;
    • Williams, Gareth J.;
    • Hopper, John L.;
    • Southey, Melissa C.;
    • Andrulis, Irene L.;
    • John, Esther M.;
    • Goldgar, David E.;
    • Lesueur, Fabienne;
    • Tavtigia, Sean V.
    Publication type:
    Article
    39
    40
    41
    42
    43

    VAV3 mediates resistance to breast cancer endocrine therapy.

    Published in:
    Breast Cancer Research, 2014, v. 16, n. 3, p. 1, doi. 10.1186/bcr3664
    By:
    • Aguilar, Helena;
    • Urruticoechea, Ander;
    • Halonen, Pasi;
    • Kiyotani, Kazuma;
    • Mushiroda, Taisei;
    • Barril, Xavier;
    • Serra-Musach, Jordi;
    • Islam, Abul;
    • Caizzi, Livia;
    • Croce, Luciano Di;
    • Nevedomskaya, Ekaterina;
    • Zwart, Wilbert;
    • Bostner, Josefine;
    • Karlsson, Elin;
    • Tenorio, Gizeh Pérez;
    • Fornander, Tommy;
    • Sgroi, Dennis C.;
    • Garcia-Mata, Rafael;
    • Jansen, Maurice P.H.M.;
    • García, Nadia
    Publication type:
    Article
    44
    45
    46
    47

    Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

    Published in:
    Breast Cancer Research, 2014, v. 16, n. 3, p. 2, doi. 10.1186/bcr3662
    By:
    • Johnson, Nichola;
    • Dudbridge, Frank;
    • Orr, Nick;
    • Gibson, Lorna;
    • Jones, Michael E.;
    • Schoemaker, Minouk J.;
    • Folkerd, Elizabeth J.;
    • Haynes, Ben P.;
    • Hopper, John L.;
    • Southey, Melissa C.;
    • Dite, Gillian S.;
    • Apicella, Carmel;
    • Schmidt, Marjanka K.;
    • Broeks, Annegien;
    • Van't Veer, Laura J.;
    • Atsma, Femke;
    • Muir, Kenneth;
    • Lophatananon, Artitaya;
    • Fasching, Peter A.;
    • Beckmann, Matthias W.
    Publication type:
    Article
    48